Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes

@article{Soon2007QuantificationOS,
  title={Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes},
  author={Derek Tuck Loong Soon and D J Tozer and Daniel R. Altmann and Paul S. Tofts and D. H. Miller},
  journal={Multiple Sclerosis},
  year={2007},
  volume={13},
  pages={884 - 894}
}
Few attempts have been made to detect subtle blood-brain barrier (BBB) leakage in visibly non-enhancing MRI lesions in multiple sclerosis (MS). For 19 patients, longitudinal relaxation time (T1) maps were generated from MRI scans obtained before, and at 20, 40 and 60 minutes after injection of gadolinium (Gd)-DTPA (0.3 mmol/kg). Regions of interest (ROI) were placed around non-enhancing lesions, and in paired contralateral normal appearing brain tissue (NABT). Post-Gd rate of R1 (=1/T1) rise… 

Figures and Tables from this paper

Blood-brain barrier breakdown in non-enhancing multiple sclerosis lesions detected by 7-Tesla MP2RAGE ΔT1 mapping

Investigation of the changes in T1 relaxation time caused by contrast on 7T MP2RAGE reveals clinically relevant evidence of BBB breakdown in NELs in MS, and suggests that NEL ΔT1 should be evaluated further as a potential biomarker of persistently disrupted BBB in MS.

Quantification of blood-to-brain transfer rate in multiple sclerosis.

Characterizing contrast-enhancing and re-enhancing lesions in multiple sclerosis

Nearly 20% of CELs represent the reoccurrence of enhancement in chronic plaques, not necessarily associated with larger areas of edema, in patients with multiple sclerosis.

Imaging patterns of inflammation in multiple sclerosis: a multifocal approach

The new nano-particle SHU555C provides complementary information to Gd-enhanced MRI, probably related to monocyte infiltration, and is likely to lead to more insight in the pluriformity of inflammation in multiple sclerosis.

Cerebral lesions of multiple sclerosis: is gadolinium always irreplaceable in assessing lesion activity?

The presence of an accompanying peripheral thin rim of hypointensity on T2-weighted images related best with contrast enhancement and subsequent lesion activity and may represent an additional pattern for disease activity assessment when gadolinium examination is contraindicated or influenced by prior therapy.

Quantitative measurement of blood‐brain barrier permeability in human using dynamic contrast‐enhanced MRI with fast T1 mapping

Dynamic contrast‐enhanced magnetic resonance imaging with low dose Gd‐DTPA and fast T1 imaging is a sensitive method to measure subtle differences in BBB permeability in humans and may have advantages over techniques based purely on the measurement of pixel contrast changes.

Multiple sclerosis lesion formation and early evolution revisited: A weekly high-resolution magnetic resonance imaging study

Findings are consistent with the existence of a subpopulation of lesions with an ‘inside-out’ genesis, where neurodegenerative processes might precede microglial activation, and a subsequent adaptive immune response.

Extended perfusion protocol for MS lesion quantification

The previously proposed time-extended DCE protocol, called Snaps, provides additional temporal perfusion information at the expense of a minimal extension of the conventional DCE acquisition time.

MRI in multiple sclerosis: an intra-individual, randomized and multicentric comparison of gadobutrol with gadoterate meglumine at 3 T

Both gadobutrol and gadoterate meglumine can be used for imaging of acute inflammatory MS lesions, however, gadOButrol generates higher lesion SI than gadoterates meglumsine, and subjective preference rating showed non-significant tendency in favour of gadobUTrol.
...

References

SHOWING 1-10 OF 46 REFERENCES

Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: Application of an extended blood‐brain barrier leakage correction

The results indicate that the acute phase in MS is accompanied by vasodilation, and in later stages of gliosis, the perfusion decreases with increasing axonal injury.

Quantitative contrast-enhanced magnetic resonance imaging to evaluate blood-brain barrier integrity in multiple sclerosis: a preliminary study

The persistent increases in signal intensity in non-enhancing lesions suggest more widespread abnormalities in BBB than is visually apparent, but substantiation of BBB leakage in normal appearing white matter will require further study using more sensitive methods.

Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study.

The authors' data indicate that inflammation is accompanied by altered local perfusion, which can be detected prior to permeability of the BBB, and changes of perfusion parameters were detectable not only prior to theBBB breakdown, but also prior to increases in the ADC.

Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images.

It is speculated that diminished MTR may reflect diminished myelin content and that hypointensity on T1-weighted images corresponds to demyelination in multiple sclerosis lesions.

Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity.

DSC-MRI measurements demonstrate potential for investigating hemodynamic abnormalities that are associated with inflammatory activity, lesion reactivity and vascular compromise in MS lesions and can be observed on quantitative color-coded maps even without blood-brain barrier breakdown.

Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts

Leakage of Gd‐DTPA through a defective blood‐brain barrier is measured quantitatively using dynamic MRI scanning, in which repeated scans are made after a bolus injection, and implies permeability in the range 4‐17 × 10−6 cm s−1, in broad agreement with other physiological methods.

Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2* contrast‐enhanced dynamic MR imaging

Results from this study suggest that in assessing the angiogenic activities in brain tumors it is advisable to monitor simultaneously changes in tumor blood volume, vessel permeability, and leakage space of tumor neovasculature.

Abnormalities of cerebral perfusion in multiple sclerosis

This study investigated perfusion changes in differing MS clinical subgroups on or off β-interferon therapy using a non-invasive MRI technique to investigate whether different clinical MS subtypes displayed perfusions changes and whether this could give a further insight into the pathological mechanisms involved.

MR venography of multiple sclerosis.

With MR venography, the perivenous distribution of MS lesions in the brain can be visualized in vivo and the venous anatomy defines the typical form and orientation of these lesions.

Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis

DTI detects diffuse abnormalities in the normal-appearing white matter of MS patients, and the findings in lesions appear to relate to pathologic severity, and its use in serial studies and in larger clinical cohorts may increase the understanding of pathogenetic mechanisms of reversible and persistent disability.